(1)Huajun Zhao, Qiuju Han, Guan Wang, Ang Lin, Dongqing Xu, Yaqun Wang, Lianhui Zhao, Zhigang Tian, Jian Zhang*. Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells.Gut2019;68(11):2032-2043.
(2)Huajun Zhao, Yating Yu, Yucan Wang, Ailu Yang, Yifei Hu, Zhaoyi Pan, Ang Lin, Guan Wang, Zixuan Wang, Jiarui Yang, Qiuju Han, Zhigang Tian, Jian Zhang*. Cholesterol accumulation in dendritic cells increases therapeutic vaccine efficacy against HBV.Cell Mol Immunol2022;19(12):1347-1360.
(3)Weijun Zhao#,Huajun Zhao#, Baoying Huang#, Tongyi Zhao#, Limei Wang, Jian Zhang, Yong Yang, Xinying Tang*, Wenjie Tan*, Ang Lin*. Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination.Signal Transduction and Targeted Therapy2022;7(1):210.
(4)Xiao Liang#,Huajun Zhao#, Jintong Du#, Xue Li, Kangshuai Li, Zhongcheng Zhao, Wenchao Bi, Xiaotong Zhang, Dian Yu, Jian Zhang, Hao Fang*, Xuben Hou*. Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.Eur J Med Chem2023;258:115599.
(5)Huajun Zhao, Qiuju Han, Ailu Yang, Yucan Wang, Guan Wang, Ang Lin, Xiao Wang, Chunlai Yin, Jian Zhang*. CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV.Int J Biol Sci2022;18(1):154-165.
(6)Huajun Zhao, Haigang Wang, Yifei Hu, Dongqing Xu, Chunlai Yin, Qiuju Han, Jian Zhang*. Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV.Int J Nanomedicine2021;16:4913-4928.
(7)Huajun Zhao, Yifei Hu, Qiuju Han, Jian Zhang*. Innate and adaptive immune escape mechanisms of hepatitis B virus.World J Gastroenterol2022;28:881-896.